Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Dr. Hönle AG
  6. Summary
    HNL   DE0005157101

DR. HÖNLE AG

(HNL)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
07/26/2021 07/27/2021 07/28/2021 07/29/2021 07/30/2021 Date
48.7(c) 46.95(c) 47.75(c) 49.25(c) 48.5(c) Last
1 473 1 654 795 1 423 2 496 Volume
0.00% -3.59% +1.70% +3.14% -1.52% Change
More quotes
Estimated financial data (e)
Sales 2021 121 M 143 M 143 M
Net income 2021 11,6 M 13,8 M 13,8 M
Net Debt 2021 20,7 M 24,6 M 24,6 M
P/E ratio 2021 25,4x
Yield 2021 1,96%
Sales 2022 149 M 177 M 177 M
Net income 2022 20,9 M 24,7 M 24,7 M
Net Debt 2022 13,1 M 15,5 M 15,5 M
P/E ratio 2022 14,1x
Yield 2022 2,27%
Capitalization 294 M 349 M 349 M
EV / Sales 2021 2,60x
EV / Sales 2022 2,06x
Nbr of Employees 614
Free-Float 83,0%
More Financials
Company
Dr Hoenle AG is a Germany-based company engaged in the basic materials and industrials sectors. The Company develops, manufactures and supplies ultraviolet (UV) equipment. The Company operates three business segments: Equipment and Systems, Adhesives, and Glass and Lamps. The Equipment and Systems segment encompasses the development, production and sale of UV equipment and systems used for drying inks and coatings,... 
More about the company
Ratings of Dr. Hönle AG
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about DR. HÖNLE AG
07/21DR HOENLE AG : Receives a Buy rating from Warburg Research
MD
05/18DR HOENLE AG : Warburg Research gives a Buy rating
MD
05/12Dr. Hönle Ag Reports Earnings Results for the Second Quarter Ended March 31, ..
CI
03/24DR. HÖNLE AG : Ex-dividend day for final dividend
FA
01/28Dr. Hönle Ag Reports Earnings Results for the Full Year Ended September 30, 2..
CI
2020DR. HÖNLE AG(XTRA : HNL) dropped from Germany SDAX (Total Return) Index
CI
2020DR HOENLE AG : Hauck & Aufhauser gives a Buy rating
MD
2020DR HOENLE AG : Warburg Research maintains a Buy rating
MD
2020Dr. Hönle AG completed the acquisition of STERILSYSTEMS GmbH.
CI
2020DR HOENLE AG : Warburg Research keeps its Buy rating
MD
2020DR HÖNLE : Übernahme im Bereich Life Science
PU
2020PTA-NEWS : Dr. Hönle AG: Übernahme im Bereich Life Science
PU
2020DR HOENLE AG : Gets a Buy rating from Warburg Research
MD
2020DR HOENLE AG : Buy rating from Hauck & Aufhauser
MD
2020Dr. Hönle AG agreed to acquire STERILSYSTEMS GmbH.
CI
More news
News in other languages on DR. HÖNLE AG
07/22DR HÖNLE : Grünen-Politiker und MdB Dieter Janecek informiert sich bei Dr. Hönle..
07/21DR HÖNLE : Premiere des Musiktheaters IMAL dank UVC-Entkeimung
07/19DR HÖNLE : Hönle präsentiert Einsatz von UVC-Luftentkeimern in Grund-und Mittels..
07/15PTA-ADHOC : Dr. Hönle AG: Förderung mobiler Luftentkeimungsgeräte bietet starke ..
07/15PTA-ADHOC : Dr. Hönle AG: Förderung mobiler Luftentkeimungsgeräte bietet starke ..
More news
Analyst Recommendations on DR. HÖNLE AG
More recommendations
Chart DR. HÖNLE AG
Duration : Period :
Dr. Hönle AG Technical Analysis Chart | HNL | DE0005157101 | MarketScreener
Technical analysis trends DR. HÖNLE AG
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 48,50 €
Average target price 66,25 €
Spread / Average Target 36,6%
EPS Revisions
Managers and Directors
Norbert Haimerl Co-Managing Director & Chief Financial Officer
Heiko Runge Co-Managing Director, CTO & Sales Head
Karl Hönle Chairman-Supervisory Board
Günther Henrich Vice Chairman-Supervisory Board
Bernhard Gimple Independent Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
DR. HÖNLE AG-11.50%349
ATLAS COPCO AB38.21%78 182
FANUC CORPORATION-3.86%42 606
PARKER-HANNIFIN CORPORATION14.54%40 269
TECHTRONIC INDUSTRIES COMPANY LIMITED25.59%32 765
SANDVIK AB11.43%32 715